Last updated: 2026-09-23 13:53:40. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Johnson & Johnson (JNJ) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $270.59, with a market capitalization of $649.40B and a P/E ratio of 30.84. Over the past 52 weeks, its price has ranged from $174.83 to $281.07. This page covers its latest market performance, valuation, price trends and company information.
$649.40B | |
$269.47 | |
$281.07 | |
$46.25 | |
$269.19 | |
347.31K | |
7.32M | |
30.84 | |
$281.07 | |
$174.83 | |
1.95% | |
-- |
Johnson & Johnson (JNJ) is currently trading at $270.59 as of 2026-09-23 13:37:00, up 0.52% ($1.40) from the previous close of $269.19
During today's regular trading session, JNJ has traded between $46.25 and $281.07, with a trading volume of 347.31K shares. The current price is near the upper end of today's range.
Over the past seven days, Johnson & Johnson (JNJ) moved from $266.32 to $270.59, representing a gain of 1.60% ($4.27).
The stock traded between $260.68 and $273.73 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 6.87 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 90.1%
JNJ is currently trading at $270.59, placing it 90.1% of the way from its 52-week low of $174.83 to its 52-week high of $281.07. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 140800 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Johnson & Johnson (JNJ) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.